Design, Synthesis, and In-silico Evaluation of Benzyl oxybenzoate Derivatives as Dual HDAC Inhibitors for Cancer and CNS Disorders. AJPS [Internet]. 2026 Jan. 7 [cited 2026 Jul. 7];25(5):917-30. Available from: https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/1307